Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases

Email Alerts

Receive email updates about meeting announcements. Learn more.

Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases

Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases Banner

Agenda

Monday, September 12, 2011

7:00 a.m.	Registration
8:00 a.m.	Welcome and Introductions
	Susan B. Shurin, M.D., Acting Director National Heart, Lung, and Blood Institute
8:10 a.m.	Opening Remarks
	Christopher J. O’Donnell, M.D., M.P.H. National Heart, Lung, and Blood Institute
8:25 – 11:30 a.m.	Session I: From Human Genome Sequence to GWAS
	Moderators: Scott T. Weiss, M.D. Harvard Medical School / Brigham and Women’s Hospital Dina N. Paltoo, Ph.D., M.P.H. National Heart, Lung, and Blood Institute Opening Remarks Moderators Keynote Address Use of Next Generation Sequencing for Disease Gene Discovery Richard P. Lifton, M.D., Ph.D. Yale University Genes for Cardiac Repolarization and Sudden Cardiac Death Aravinda Chakravarti, Ph.D. Johns Hopkins University Asthma Gene Discovery in the EVE Consortium Carole Ober, Ph.D. University of Chicago
9:45 a.m.	Break
10:15 a.m.	Genetic Determinants of Hematologic Traits in the Population Santhi Ganesh, M.D. University of Michigan Pharmacogenetic Advances in Cardiovascular Disease Donna K. Arnett, Ph.D., M.S.P.H. University of Alabama at Birmingham Progress in COPD Genetics Edwin K. Silverman, M.D., Ph.D. Harvard Medical School / Brigham and Women’s Hospital
11:30 a.m.	Lunch (on your own)
12:30 p.m.	Oral Abstract Presentations Catherine Y. Campbell, M.D. Cardiology Fellow Johns Hopkins University School of Medicine Jie Huang, M.D., M.P.H. Research Fellow NHLBI / Framingham Heart Study
1:00 – 3:10 p.m.	Session II: From GWAS to Function
	Moderators: Stuart H. Orkin, M.D. Harvard Medical School / Children’s Hospital Boston Alan M. Michelson, M.D., Ph.D. National Heart, Lung, and Blood Institute Opening Remarks Moderators MUC5B and Pulmonary Fibrosis David A. Schwartz, M.D. National Jewish Health In Vivo Discovery of Mammalian Heart Enhancers Len A. Pennacchio, Ph.D. Department of Energy Joint Genome Project From GWAS-Identified Locus to Reversing the Fetal Hemoglobin Switch: Functional and Genetic Validation Stuart H. Orkin, M.D. Harvard Medical School / Children’s Hospital Boston Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2 Thomas Quertermous, M.D. Stanford University School of Medicine Programming and Reprogramming: New Approaches to Understanding Disease Chad Cowan, Ph.D. Harvard Medical School / Massachusetts General Hospital
3:10 p.m.	Break
3:40 – 5:00 p.m.	Session III: From GWAS to Discovery: Genetic Analysis Moderators: Eric Boerwinkle, Ph.D. University of Texas Health Science Center L. Adrienne Cupples, Ph.D. Boston University Opening Remarks Moderators Analysis Considerations for Genome-Wide Studies for CVD Phenotypes in Multi-Ethnic Populations Leslie Lange, Ph.D. University of North Carolina at Chapel Hill When Is a Large Sample Not So Large? Some Non-Intuitive Behavior in High-Throughput Association Analyses Kenneth Rice, Ph.D. University of Washington Detecting Complex Trait Associations With Rare Variants Suzanne M. Leal, Ph.D. Baylor College of Medicine
5:00 p.m.	Poster Abstract Presentation Session
6:30 p.m.	Adjourn

Tuesday, September 13, 2011

7:30 a.m.	Registration
8:00 – 11:30 a.m.	Session IV: From GWAS to Sequencing
	Moderators: Stephen Rich, Ph.D. University of Virginia Deborah Nickerson, Ph.D. University of Washington Opening Remarks Moderators Life After GWAS: Sequencing and Functional Studies in the CHARGE Consortium Eric Boerwinkle, Ph.D. University of Texas Health Science Center Rare Coding Mutations and Risk for Myocardial Infarction Sekar Kathiresan, M.D. Harvard Medical School/Massachusetts General Hospital Advances in Lipid Genetics from Large Scale Genetic Studies Cristen J. Willer, Ph.D. University of Michigan Rare Variant Discovery in Dilated Cardiomyopathy Ray E. Hershberger, M.D. University of Miami Miller School of Medicine
9:45 a.m.	Break
10:05 a.m.	Sequencing Thousands of Individuals to Study Complex Traits Gonçalo Abecasis, Ph.D. University of Michigan School of Public Health Emerging Technologies in Genomics Jay A. Shendure, M.D., Ph.D. University of Washington School of Medicine Oral Abstract Presentations Chunyu Liu, Ph.D. Staff Scientist National Heart, Lung, and Blood Institute / Framingham Heart Study Joshua W. Knowles, M.D., Ph.D. Instructor, Cardiovascular Medicine Stanford University School of Medicine
11:30 a.m.	Lunch (on your own)
1:00 – 1:30 p.m.	Oral Abstract Presentations Adam Gordon Graduate Student University of Washington Joshua Diamond, M.D., M.S.C.E. Fellow, Pulmonary, Allergy, and Critical Care University of Pennsylvania
1:30 – 3:15 p.m.	Session V: From Genomics to Clinical Translation
	Moderators: Thomas Quertermous, M.D. Stanford University School of Medicine Cashell Jaquish, Ph.D. National Heart, Lung, and Blood Institute Opening Remarks Moderators Next-Gen Sequencing of Cardiomyopathies: Insights Into Etiologies and Mechanisms Christine E. Seidman, M.D. Harvard Medical School Pharmacogenomics of Anti-Platelet Agents: The PAPI Study Alan R. Shuldiner, M.D. University of Maryland School of Medicine Implementing Genomics in An Electronic Medical Record Environment: Early Lessons Dan M. Roden, M.D. Vanderbilt Medical Center Functional Validation of Novel Genes At GWAS Loci for Plasma Lipid Traits Daniel J. Rader, M.D. University of Pennsylvania School of Medicine
3:15 p.m.	Closing Remarks Christopher J. O’Donnell, M.D., M.P.H. National Heart, Lung, and Blood Institute
3:20 p.m.	Adjourn

Twitter

Facebook

YouTube